Is CARL or CNXU more profitable?

Conexeu Sciences has a net margin of 0.00% compared to Carlsmed's net margin of -57.42%. Carlsmed's return on equity of -38.06% beat Conexeu Sciences' return on equity. Company Net Margins Return on Equity Return on Assets Carlsmed -57.42% -38.06% -28.96% Conexeu Sciences N/A -200.20% -177.26%

Does the media favor CARL or CNXU?

In the previous week, Carlsmed had 4 more articles in the media than Conexeu Sciences. MarketBeat recorded 9 mentions for Carlsmed and 5 mentions for Conexeu Sciences. Carlsmed's average media sentiment score of 0.92 beat Conexeu Sciences' score of 0.48 indicating that Carlsmed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Carlsmed 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Conexeu Sciences 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer SI or CNXU?

In the previous week, Shoulder Innovations had 1 more articles in the media than Conexeu Sciences. MarketBeat recorded 6 mentions for Shoulder Innovations and 5 mentions for Conexeu Sciences. Shoulder Innovations' average media sentiment score of 0.48 beat Conexeu Sciences' score of 0.48 indicating that Shoulder Innovations is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Shoulder Innovations 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Conexeu Sciences 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer OFIX or CNXU?

In the previous week, Orthofix Medical and Orthofix Medical both had 5 articles in the media. Conexeu Sciences' average media sentiment score of 0.48 beat Orthofix Medical's score of 0.24 indicating that Conexeu Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Orthofix Medical 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Conexeu Sciences 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Conexeu Sciences (CNXU) Competitors

$3.77 -0.12 (-3.08%)

Closing price 10/12/2026 04:00 PM Eastern

Extended Trading

$3.86 +0.10 (+2.52%)

As of 10/12/2026 07:54 PM Eastern

Compare

CNXU vs. CARL, SENS, SI, OFIX, and OBIO

Should you buy Conexeu Sciences stock or one of its competitors? Conexeu Sciences's main competitors and comparable companies include Carlsmed (CARL), Senseonics Holdings, Inc. Common Stock (SENS), Shoulder Innovations (SI), Orthofix Medical (OFIX), and Orchestra BioMed (OBIO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Conexeu Sciences compare to Carlsmed?

Carlsmed (NASDAQ:CARL) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, media sentiment, risk and dividends.

In the previous week, Carlsmed had 4 more articles in the media than Conexeu Sciences. MarketBeat recorded 9 mentions for Carlsmed and 5 mentions for Conexeu Sciences. Carlsmed's average media sentiment score of 0.92 beat Conexeu Sciences' score of 0.48 indicating that Carlsmed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Carlsmed	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Conexeu Sciences	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Conexeu Sciences has lower revenue, but higher earnings than Carlsmed. Carlsmed is trading at a lower price-to-earnings ratio than Conexeu Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Carlsmed	$63.30M	6.38	-$29.63M	-$1.43	N/A
Conexeu Sciences	N/A	N/A	-$3.92M	-$0.40	N/A

Carlsmed presently has a consensus price target of $19.50, indicating a potential upside of 31.94%. Conexeu Sciences has a consensus price target of $20.00, indicating a potential upside of 430.50%. Given Conexeu Sciences' higher probable upside, analysts clearly believe Conexeu Sciences is more favorable than Carlsmed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Conexeu Sciences	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Conexeu Sciences has a net margin of 0.00% compared to Carlsmed's net margin of -57.42%. Carlsmed's return on equity of -38.06% beat Conexeu Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Carlsmed	-57.42%	-38.06%	-28.96%
Conexeu Sciences	N/A	-200.20%	-177.26%

Summary

Carlsmed beats Conexeu Sciences on 7 of the 12 factors compared between the two stocks.

How does Conexeu Sciences compare to Senseonics Holdings, Inc. Common Stock?

Conexeu Sciences (NASDAQ:CNXU) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership and media sentiment.

12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Conexeu Sciences has a net margin of 0.00% compared to Senseonics Holdings, Inc. Common Stock's net margin of -225.09%. Senseonics Holdings, Inc. Common Stock's return on equity of -165.80% beat Conexeu Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	-200.20%	-177.26%
Senseonics Holdings, Inc. Common Stock	-225.09%	-165.80%	-80.14%

Conexeu Sciences has higher earnings, but lower revenue than Senseonics Holdings, Inc. Common Stock. Conexeu Sciences is trading at a lower price-to-earnings ratio than Senseonics Holdings, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	-$3.92M	-$0.40	N/A
Senseonics Holdings, Inc. Common Stock	$35.26M	10.95	-$69.11M	-$2.23	N/A

Conexeu Sciences presently has a consensus target price of $20.00, indicating a potential upside of 430.50%. Senseonics Holdings, Inc. Common Stock has a consensus target price of $13.00, indicating a potential upside of 40.69%. Given Conexeu Sciences' higher possible upside, equities analysts plainly believe Conexeu Sciences is more favorable than Senseonics Holdings, Inc. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Senseonics Holdings, Inc. Common Stock	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Conexeu Sciences had 2 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 5 mentions for Conexeu Sciences and 3 mentions for Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock's average media sentiment score of 1.13 beat Conexeu Sciences' score of 0.48 indicating that Senseonics Holdings, Inc. Common Stock is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Senseonics Holdings, Inc. Common Stock	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Senseonics Holdings, Inc. Common Stock beats Conexeu Sciences on 9 of the 14 factors compared between the two stocks.

How does Conexeu Sciences compare to Shoulder Innovations?

Shoulder Innovations (NYSE:SI) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment.

Conexeu Sciences has a net margin of 0.00% compared to Shoulder Innovations' net margin of -58.33%. Shoulder Innovations' return on equity of -23.61% beat Conexeu Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shoulder Innovations	-58.33%	-23.61%	-19.53%
Conexeu Sciences	N/A	-200.20%	-177.26%

Conexeu Sciences has lower revenue, but higher earnings than Shoulder Innovations. Shoulder Innovations is trading at a lower price-to-earnings ratio than Conexeu Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shoulder Innovations	$47.32M	8.07	-$40.36M	-$1.92	N/A
Conexeu Sciences	N/A	N/A	-$3.92M	-$0.40	N/A

In the previous week, Shoulder Innovations had 1 more articles in the media than Conexeu Sciences. MarketBeat recorded 6 mentions for Shoulder Innovations and 5 mentions for Conexeu Sciences. Shoulder Innovations' average media sentiment score of 0.48 beat Conexeu Sciences' score of 0.48 indicating that Shoulder Innovations is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Shoulder Innovations	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Conexeu Sciences	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Shoulder Innovations presently has a consensus price target of $25.75, indicating a potential upside of 40.44%. Conexeu Sciences has a consensus price target of $20.00, indicating a potential upside of 430.50%. Given Conexeu Sciences' higher probable upside, analysts plainly believe Conexeu Sciences is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shoulder Innovations	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67
Conexeu Sciences	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Shoulder Innovations beats Conexeu Sciences on 7 of the 12 factors compared between the two stocks.

How does Conexeu Sciences compare to Orthofix Medical?

Orthofix Medical (NASDAQ:OFIX) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, risk, valuation, profitability and analyst recommendations.

Conexeu Sciences has lower revenue, but higher earnings than Orthofix Medical. Conexeu Sciences is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Orthofix Medical	$822.31M	0.46	-$92.19M	-$1.54	N/A
Conexeu Sciences	N/A	N/A	-$3.92M	-$0.40	N/A

Conexeu Sciences has a net margin of 0.00% compared to Orthofix Medical's net margin of -7.41%. Orthofix Medical's return on equity of -14.05% beat Conexeu Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Orthofix Medical	-7.41%	-14.05%	-7.17%
Conexeu Sciences	N/A	-200.20%	-177.26%

89.8% of Orthofix Medical shares are owned by institutional investors. 2.7% of Orthofix Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Orthofix Medical currently has a consensus target price of $14.75, indicating a potential upside of 58.94%. Conexeu Sciences has a consensus target price of $20.00, indicating a potential upside of 430.50%. Given Conexeu Sciences' higher probable upside, analysts clearly believe Conexeu Sciences is more favorable than Orthofix Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Orthofix Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Conexeu Sciences	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Orthofix Medical and Orthofix Medical both had 5 articles in the media. Conexeu Sciences' average media sentiment score of 0.48 beat Orthofix Medical's score of 0.24 indicating that Conexeu Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Orthofix Medical	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Conexeu Sciences	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Orthofix Medical beats Conexeu Sciences on 8 of the 13 factors compared between the two stocks.

How does Conexeu Sciences compare to Orchestra BioMed?

Orchestra BioMed (NASDAQ:OBIO) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, media sentiment, risk, profitability, analyst recommendations and dividends.

Orchestra BioMed presently has a consensus target price of $13.17, suggesting a potential upside of 122.79%. Conexeu Sciences has a consensus target price of $20.00, suggesting a potential upside of 430.50%. Given Conexeu Sciences' higher possible upside, analysts clearly believe Conexeu Sciences is more favorable than Orchestra BioMed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Orchestra BioMed	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71
Conexeu Sciences	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Conexeu Sciences has a net margin of 0.00% compared to Orchestra BioMed's net margin of -184.60%. Orchestra BioMed's return on equity of -149.61% beat Conexeu Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Orchestra BioMed	-184.60%	-149.61%	-54.15%
Conexeu Sciences	N/A	-200.20%	-177.26%

In the previous week, Conexeu Sciences had 4 more articles in the media than Orchestra BioMed. MarketBeat recorded 5 mentions for Conexeu Sciences and 1 mentions for Orchestra BioMed. Orchestra BioMed's average media sentiment score of 1.05 beat Conexeu Sciences' score of 0.48 indicating that Orchestra BioMed is being referred to more favorably in the media.

Company	Overall Sentiment
Orchestra BioMed	Positive
Conexeu Sciences	Neutral

53.2% of Orchestra BioMed shares are owned by institutional investors. 7.5% of Orchestra BioMed shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Conexeu Sciences has lower revenue, but higher earnings than Orchestra BioMed. Conexeu Sciences is trading at a lower price-to-earnings ratio than Orchestra BioMed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Orchestra BioMed	$33.48M	10.61	-$52.70M	-$0.85	N/A
Conexeu Sciences	N/A	N/A	-$3.92M	-$0.40	N/A

Summary

Orchestra BioMed beats Conexeu Sciences on 9 of the 14 factors compared between the two stocks.

Get Conexeu Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNXU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CNXU vs. The Competition

Export

Metric	Conexeu Sciences	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$109.72M	$5.52B	$7.27B	$13.27B
Dividend Yield	N/A	1.76%	2.52%	20.73%
P/E Ratio	-9.43	25.89	275.35	25.82
Price / Sales	N/A	83.73	582.04	91.81
Price / Cash	N/A	32.56	27.30	36.12
Price / Book	N/A	6.01	10.85	6.10
Net Income	-$3.92M	$146.14M	$3.50B	$380.59M
7 Day Performance	3.01%	-0.46%	-1.29%	-2.03%
1 Month Performance	-15.47%	-2.17%	-4.88%	-4.22%
1 Year Performance	N/A	3.02%	5.66%	-1.55%

Conexeu Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CNXU Conexeu Sciences	2.1888 of 5 stars	$3.77 -3.1%	$20.00 +430.5%	N/A	$109.72M	N/A	N/A	4	Gap Up
CARL Carlsmed	2.5859 of 5 stars	$14.42 +2.6%	$19.25 +33.5%	+12.7%	$383.61M	$63.30M	N/A	127	News Coverage Analyst Forecast
SENS Senseonics Holdings, Inc. Common Stock	3.4412 of 5 stars	$8.98 -0.4%	$13.00 +44.8%	N/A	$377.06M	$35.26M	N/A	130	Positive News
SI Shoulder Innovations	2.7622 of 5 stars	$18.15 +1.5%	$25.50 +40.5%	+46.7%	$372.45M	$47.32M	N/A	75	News Coverage Analyst Forecast
OFIX Orthofix Medical	2.7074 of 5 stars	$9.17 +1.9%	$14.75 +60.9%	-34.6%	$366.59M	$822.31M	N/A	1,605	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CNXU) was last updated on 10/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Conexeu Sciences (CNXU) Competitors

CNXU vs. CARL, SENS, SI, OFIX, and OBIO

How does Conexeu Sciences compare to Carlsmed?

Summary

How does Conexeu Sciences compare to Senseonics Holdings, Inc. Common Stock?

Summary

How does Conexeu Sciences compare to Shoulder Innovations?

Summary

How does Conexeu Sciences compare to Orthofix Medical?

Summary

How does Conexeu Sciences compare to Orchestra BioMed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNXU vs. The Competition

Conexeu Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Conexeu Sciences (CNXU) Competitors

CNXU vs. CARL, SENS, SI, OFIX, and OBIO

How does Conexeu Sciences compare to Carlsmed?

Does the media favor CARL or CNXU?

Which has preferable valuation & earnings, CARL or CNXU?

Do analysts recommend CARL or CNXU?

Is CARL or CNXU more profitable?

Summary

How does Conexeu Sciences compare to Senseonics Holdings, Inc. Common Stock?

Do institutionals and insiders believe in CNXU or SENS?

Is CNXU or SENS more profitable?

Which has better valuation & earnings, CNXU or SENS?

Do analysts prefer CNXU or SENS?

Does the media prefer CNXU or SENS?

Summary

How does Conexeu Sciences compare to Shoulder Innovations?

Is SI or CNXU more profitable?

Which has stronger earnings and valuation, SI or CNXU?

Does the media prefer SI or CNXU?

Do analysts rate SI or CNXU?

Summary

How does Conexeu Sciences compare to Orthofix Medical?

Which has better earnings & valuation, OFIX or CNXU?

Is OFIX or CNXU more profitable?

Do institutionals & insiders have more ownership in OFIX or CNXU?

Do analysts rate OFIX or CNXU?

Does the media prefer OFIX or CNXU?

Summary

How does Conexeu Sciences compare to Orchestra BioMed?

Do analysts rate OBIO or CNXU?

Is OBIO or CNXU more profitable?

Does the media prefer OBIO or CNXU?

Do insiders & institutionals hold more shares of OBIO or CNXU?

Which has stronger valuation & earnings, OBIO or CNXU?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNXU vs. The Competition

Conexeu Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools